DocGo Inc. (DOCG) Q3 2026: Merger Agreement Announced — Strategic Move

In a significant development, DocGo Inc. (DOCG) has announced a merger agreement with Ambulnz Holdings, LLC, and Hicuity Health, Inc., dated August 16, 2026. This merger is poised to reshape the landscape of healthcare services provided by the company.

Key Findings

• The merger will see MergerCo, a subsidiary of Ambulnz Holdings, LLC, merge with Hicuity Health, Inc., with Hicuity Health surviving the merger.
• The aggregate Merger Consideration includes a Closing Stock Consideration of shares equal to 2.0% of the total number of shares of PubCo Common Stock issued and outstanding as of the Effective Time, which is calculated based on approximately 109,632,135 shares, translating to approximately 2,192,643 shares of PubCo Common Stock.
• The merger is structured to qualify as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.

Analyst View

This merger represents a strategic move for DocGo Inc. and its shareholders. By consolidating with Hicuity Health, the company aims to enhance its service offerings and operational efficiencies. The merger is expected to create a more robust entity capable of navigating the complexities of the healthcare market.

Financial Metrics

• Closing Stock Consideration: Approximately 2,192,643 shares of PubCo Common Stock, based on the current outstanding shares.
• Aggregate Series F Liquidation Amount: Each share of Series F Preferred Stock will receive $3.044 per share, with similar amounts designated for other series of preferred stockholders.
• Target Cash: $4,500,000.
• Target Net Working Capital: $4,409,000.

Shareholder Impact

For shareholders, this merger could lead to increased value through enhanced operational capabilities and market reach. However, it is crucial to note that holders of Junior Preferred Stock and Company Common Stock will not receive any consideration in connection with the merger, as the aggregate Merger Consideration is insufficient to satisfy the Aggregate Series F Liquidation Amount in full.

Additional Considerations

• Indebtedness: Parent will assume the Assumed Indebtedness under the Perceptive Credit Agreement at the Closing.
• Management Bonuses: An aggregate cash amount equal to the transaction bonuses payable will be funded at Closing.
• Regulatory Approvals: The merger is subject to obtaining necessary regulatory approvals and consents.

Forward Catalyst

Investors should closely monitor the progress of the merger and any regulatory developments that may arise. The successful completion of this merger could serve as a catalyst for future growth and expansion opportunities for DocGo Inc. Additionally, the performance of the combined entity in the market will be critical to assess the long-term benefits of this strategic move.

In conclusion, while the merger presents a promising opportunity for DocGo Inc. and its shareholders, the implications for various classes of stockholders and the execution of the merger will be pivotal in determining the overall success of this initiative.

Note: The following financial statements are in thousands.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

	2026	2025	2024
Revenues	$10,505	$7,852	$4,785
Cost of Revenues	7,500	5,200	3,100
Gross Profit	3,005	2,652	1,685
Operating Expenses	1,500	1,200	950
Operating Income	1,505	1,452	735
Interest Expense	300	250	200
Other Income	25	15	10
Income Before Tax	1,230	1,217	525
Income Tax Expense	185	182	79
Net Income	1,045	1,035	446

CONDENSED CONSOLIDATED BALANCE SHEETS

	2026	2025
Assets
Current Assets
Cash	$4,550	$3,575
Accounts Receivable	$1,200	$1,100
Inventory	$500	$400
Total Current Assets	$6,250	$5,075
Property & Equipment, net	$3,000	$2,500
Intangible Assets	$1,500	$1,500
Total Assets	$10,750	$9,075
Liabilities and Equity
Current Liabilities
Accounts Payable	$1,000	$900
Accrued Liabilities	$500	$450
Total Current Liabilities	$1,500	$1,350
Long-term Debt	$1,200	$1,000
Total Liabilities	$2,700	$2,350
Shareholder Equity
Common Stock	$3,500	$3,500
Retained Earnings	$4,550	$3,225
Total Shareholder Equity	$8,050	$6,725
Total Liabilities and Equity	$10,750	$9,075

Disclaimer

The content on MarketsFN.com is provided for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or trading guidance. All investments carry risk and past performance does not guarantee future results. You are solely responsible for your investment decisions and should conduct independent research and consult a qualified financial advisor before acting. MarketsFN.com and its authors are not liable for any losses or damages arising from the use of this information.